Blueprint Medicines Corp: Ind for Wild-Type Kit Inhibitor Blu-808 on Track for Filing in Q2
Blueprint Medicines Corp:野生型試劑盒抑制劑Blu-808的申請有望在第二季度申報
Blueprint Medicines Corp: Ind for Wild-Type Kit Inhibitor Blu-808 on Track for Filing in Q2
Blueprint Medicines Corp:野生型試劑盒抑制劑Blu-808的申請有望在第二季度申報
使用瀏覽器的分享功能,分享給你的好友吧